Abstract:Background: In the US, ~35% of individuals on the waitlist for a liver transplant who had hepatocellular cancer (HCC) also had metabolic dysfunction-associated steatohepatitis (MASH). Yet, key signaling mechanisms controlling cellular transformation in this obesity-driven HCC remain only partially understood. SIRT6 is NAD+-dependent protein deacetylases that limits the activity of the lipogenic transcription factors SREBP1/2. Reduced SIRT6 is associated with human fatty liver and cancer. However, SIRT6 also limits liver fibrosis by inhibiting TGF-β signaling through the deacetylation of SMAD2 and SMAD3. We found that Smad3 driven TGF-β signaling is modulated by βII-Spectrin (encoded by SPTBN1), and that a hot mutation in HCC- D1089Y encompasses the SPTBN1-SMAD3 binding site (Gastro 2018; 154:195-210). In stressed hepatocytes, βII-Spectrin promotes lipogenesis through interactions between caspase-cleaved forms of both SREBP1 and βII-Spectrin (Sci Transl Med 2021;13:624). Liver-specific knockout of βII-Spectrin (LSKO) blocks fatty liver and HCC. Here we explored the extent of βII-spectrin-D1089Y regulation of SIRT6 expression through SMAD3, and the combined roles of SIRT6 and SPTBN1 in human HCC. Methods: We generated a SPTBN1-D1089Y mutant mouse and examined SIRT6 in the SPTBN1-D1089Y mutant mouse liver tissues and MEFs. TGF-β/Smad3 pathway activity was analyzed in SPTBN1-D1089Y mutant MEFs via western blot and RNA-seq. SIRT6 expression was examined in mouse MAFLD/MASH (GSE156059). Structure-based molecular docking simulations using three-dimensional structural coordinates of human SIRT6 (ID: Q8N6T7) and β2SP (ID: Q01082) from the AlphaFold database, followed by interactions between SIRT6 and SPTBN1. Results: SIRT6 levels are decreased in SPTBN1-D1089Y mutant liver cancer cell line and mouse liver tissues. TGF-β/SMAD3 pathway activity was altered in SPTBN1-D1089Y mutant MEF cells with decreased phospho-SMAD3 levels. The structural model predicted specific interactions between human SPTBN1 and SIRT6. Overexpression of Flag-SIRT6 reduced βII-Spectrin acetylation in HepG2 cells. TGF-β induced SMAD3, βII-Spectrin coimmunoprecipitation with SIRT6. SIRT6 knockdown increases nSREBP1, SCD1 (encoded by a nSREBP1 target gene), and βII-Spectrin in HepG2 cells. SIRT6 RNA expression is significantly decreased in liver macrophages from mice with NAFLD/NASH. Conclusions: Our data indicated a SMAD dependent as well as a SMAD3 independent role of SPTBN1 in regulating SIRT6. βII-spectrin-D1089Y together with SIRT6 deficiency may increase the susceptibility to MASH/HCC via regulating the crosstalk between macrophage and hepatocytes or regulating MASH and HCC. Citation Format: Kazufumi Ohshiro, Xiyan Xiang, Xiaochun Yang, Krishanu Bhowmick, Mohammad I. Hassan, Taj Mohammad, Lopa Mishra. Loss of SIRT6 diverts TGF-β signaling to promote liver cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6272.

Loss Of Transforming Growth Factor Beta Adaptor Protein Beta-2 Spectrin Leads To Delayed Liver Regeneration In Mice

Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice.

Β‐2 Spectrin is Involved in Hepatocyte Proliferation Through the Interaction of TGFβ/Smad and PI3K/AKT Signalling

Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.

Deficiency of Apoptosis-Stimulating Protein Two of P53 Promotes Liver Regeneration in Mice by Activating Mammalian Target of Rapamycin

Ppar Beta Regulates Liver Regeneration By Modulating Akt And E2f Signaling

Transforming Growth Factor‐β Signaling Confers Hepatic Stellate Cells Progenitor Features after Partial Hepatectomy

The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration

In vivo screening identifies SPP2, a secreted factor that negatively regulates liver regeneration

Liver-specific Deletion of LASS2 Delayed Regeneration of Mouse Liver after Partial Hepatectomy.

PP2Acα Positively Regulates the Termination of Liver Regeneration in Mice Through the AKT/GSK3β/Cyclin D1 Pathway.

Liver Regeneration Deficit in Mice Following Egfr and Met Elimination

Myeloid Peroxisome Proliferator-Activated Receptor Α Deficiency Accelerates Liver Regeneration Via IL-6/STAT3 Pathway after 2/3 Partial Hepatectomy in Mice

Loss of Gsα impairs liver regeneration through a defect in the crosstalk between cAMP and growth factor signaling

Abstract 6272: Loss of SIRT6 diverts TGF-β signaling to promote liver cancer

Loss Of Alpha-Catenin Elicits A Cholestatic Response And Impairs Liver Regeneration

Deficiency of Periostin Impairs Liver Regeneration in Mice after Partial Hepatectomy

Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration

Crosstalk of LKB1‐regulated and PTEN‐regulated Signals in Liver Morphogenesis and Tumor Development in Mice

Capn3 depletion causes Chk1 and Wee1 accumulation and disrupts synchronization of cell cycle reentry during liver regeneration after partial hepatectomy

Regulation of mice liver regeneration by early growth response-1 through the GGPPS/RAS/MAPK pathway.